九洲大药房2022年度报告

UNITEDSTATES SECURITIESANDEXCHANGECOMMISSIONWASHINGTON,D.C.20549 FORM20-F ☐REGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR(g)OFTHESECURITIESEXCHANGEACTOF1934 OR ☒ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 FortheFiscalyearendedMarch31,2023OR ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfromto ☐SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 DateofeventrequiringthisshellcompanyreportCommissionfilenumber:001-40724 ChinaJo-JoDrugstores,Inc. (ExactnameofRegistrantasspecifiedinitscharter) Notapplicable (TranslationofRegistrant’snameintoEnglish) CaymanIslands HaiWaiHaiTongxinMansionFloor6GongShuDistrict HangzhouCity,ZhejiangProvincePeople’sRepublicofChina,310008 (Jurisdictionofincorporationororganization)(Addressofprincipalexecutiveoffices) LeiLiu HaiWaiHaiTongxinMansionFloor6GongShuDistrictHangzhouCity,ZhejiangProvince People’sRepublicofChina,310008Tel:+86-571-88219579 (Name,telephone,Emailand/orfacsimilenumberandaddressofcompanycontactperson)SecuritiesregisteredortoberegisteredpursuanttoSection12(b)oftheAct: TitleofeachclassTradingSymbol(s) Nameofeachexchangeonwhichregistered Ordinaryshares,parvalue$0.012pershare CJJD NasdaqCapitalMarket SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct: none(TitleofClass) SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct:none (TitleofClass) Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorordinarysharesasofthecloseoftheperiodcoveredbytheannualreport.23,697,210OrdinarySharesand0PreferredSharesoutstandingasofMarch31,2023. Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.☐Yes☒No Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934.☐Yes☒No Indicatebycheckmarkwhethertheregistrant:(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days.☒Yes☐No IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedandpostedpursuanttoRule405ofRegulationS-T(§232.405ofthischapter)duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitandpostsuchfiles).☒Yes☐No Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfileroran“emerginggrowthcompany.”Seedefinitionof“acceleratedfilerandlargeacceleratedfiler”inRule12b-2oftheExchangeAct. Largeacceleratedfiler☐Acceleratedfiler ☐Non-accelerated☒ filer Emerginggrowthcompany☐ IfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancialaccountingstandardsprovidedpursuanttoSection13(a)oftheExchangeAct.☐ Indicatebycheckmarkwhethertheregistranthasfiledareportonandattestationtoitsmanagement’sassessmentoftheeffectivenessofitsinternalcontroloverfinancialreportingunderSection 404(b)oftheSarbanes-OxleyAct(15U.S.C.7262(b))bytheregisteredpublicaccountingfirmthatpreparedorissueditsauditreport.☐ IfsecuritiesareregisteredpursuanttoSection12(b)oftheAct,indicatebycheckmarkwhetherthefinancialstatementsoftheregistrantincludedinthefilingreflectthecorrectionofanerrortopreviouslyissuedfinancialstatements.☐ Indicatebycheckmarkwhetheranyofthoseerrorcorrectionsarerestatementsthatrequiredarecoveryanalysisofincentive-basedcompensationreceivedbyanyoftheregistrant’sexecutiveofficersduringtherelevantrecoveryperiodpursuantto§240.10D-1(b).☐ Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling. U.S.GAAP☒InternationalFinancialReportingStandardsasissued bytheInternationalAccountingStandardsBoard☐ Other☐ If“Other”hasbeencheckedinresponsetothepreviousquestion,indicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow.Item17☐Item18☐ Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct).☐Yes☒No Inthisannualreport: ●Referencestothe“Company”,“we”,“our”and“us”aretoChinaJo-JoDrugstores,Inc.,aCaymanIslandscompany,anditspredecessorChinaJo-JoDrugstores,Inc.,aNevadacorporation,anditsconsolidatedsubsidiaries,subsidiariescontrolledbycontractandthereforedeemedasvariableinterestentitiesunderU.S.GAAP; ●Referencesto“China”orthe“PRC”referstothePeople’sRepublicofChina,excluding,forthepurposesofthisannualreportonly,HongKong,MacauandTaiwan; ●Referencesto“RMB”and“Renminbi”refertothelegalcurrencyofChina; ●“US$,”“U.S.dollars,”“$,”and“dollars”refertothelegalcurrencyoftheUnitedStates; ●Referencesto“variableinterestentit[y][ies]”or“VIE[s]”refertoJiuzhouPharmacy,JiuzhouClinicandJiuzhouService,aswel